Brokers Offer Predictions for Canopy Growth Q3 Earnings

Canopy Growth Co. (NASDAQ:CGC) – Atb Cap Markets increased their Q3 2025 earnings per share (EPS) estimates for Canopy Growth in a note issued to investors on Monday, December 16th. Atb Cap Markets analyst F. Gomes now forecasts that the company will post earnings per share of ($0.48) for the quarter, up from their previous forecast of ($0.49). Atb Cap Markets has a “Strong Sell” rating on the stock. The consensus estimate for Canopy Growth’s current full-year earnings is ($2.38) per share. Atb Cap Markets also issued estimates for Canopy Growth’s FY2027 earnings at ($3.08) EPS, FY2028 earnings at ($14.38) EPS and FY2029 earnings at ($10.27) EPS.

Canopy Growth Stock Down 4.2 %

Shares of CGC stock opened at $2.71 on Thursday. Canopy Growth has a 12 month low of $2.71 and a 12 month high of $14.92. The company has a quick ratio of 1.07, a current ratio of 1.39 and a debt-to-equity ratio of 0.82. The firm has a market cap of $295.24 million, a PE ratio of -0.55 and a beta of 0.83. The stock has a 50 day moving average of $4.08 and a 200-day moving average of $5.42.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. PFG Investments LLC acquired a new position in Canopy Growth in the third quarter worth about $54,000. Sassicaia Capital Advisers LLC bought a new stake in shares of Canopy Growth in the 3rd quarter valued at approximately $54,000. Financial Advocates Investment Management acquired a new position in shares of Canopy Growth in the 3rd quarter worth approximately $57,000. CIBC Asset Management Inc bought a new position in shares of Canopy Growth during the 2nd quarter worth approximately $91,000. Finally, Vontobel Holding Ltd. acquired a new stake in Canopy Growth in the 3rd quarter valued at $92,000. 3.33% of the stock is currently owned by institutional investors and hedge funds.

Canopy Growth Company Profile

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.